Literature DB >> 22992806

TNF-α and IFN-γ are potential inducers of Fas-mediated keratinocyte apoptosis through activation of inducible nitric oxide synthase in toxic epidermal necrolysis.

Isabelle Viard-Leveugle1, Olivier Gaide, Dragana Jankovic, Laurence Feldmeyer, Katrin Kerl, Chris Pickard, Stéphanie Roques, Peter S Friedmann, Emmanuel Contassot, Lars E French.   

Abstract

Toxic epidermal necrolysis (TEN) is a severe immune-mediated adverse cutaneous drug eruption characterized by rapid and extensive epithelial cell death in the epidermis and mucosae. The molecular events leading to this often fatal condition are only partially understood, but evidence suggests a dual mechanism implicating a "drug"-specific immune response on one side and the onset of target cell death by proapoptotic molecules including FasL on the other side. Herein, we describe a potential molecular bridge between these two events that involves inducible nitric oxide synthase (iNOS), which is highly upregulated in the skin of TEN patients. We show that activated T cells secrete high amounts of tumor necrosis factor-α (TNF-α) and IFN-γ, and that both cytokines lead to increased expression and activity of keratinocyte iNOS. A similar observation has been made with drug-specific T lymphocytes from a TEN patient exposed to the culprit drug. The resulting increase in nitric oxide significantly upregulates keratinocyte FasL expression, resulting in Fas- and caspase-8-mediated keratinocyte cell death. Taken together, our data suggest that T-lymphocyte activation by drugs in TEN patients may indirectly lead to FasL-mediated keratinocyte apoptosis, via a molecular bridge involving TNF-α, IFN-γ, and iNOS.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22992806     DOI: 10.1038/jid.2012.330

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  29 in total

1.  Randomized, controlled trial of TNF-α antagonist in CTL-mediated severe cutaneous adverse reactions.

Authors:  Chuang-Wei Wang; Lan-Yan Yang; Chun-Bing Chen; Hsin-Chun Ho; Shuen-Iu Hung; Chih-Hsun Yang; Chee-Jen Chang; Shih-Chi Su; Rosaline Chung-Yee Hui; See-Wen Chin; Li-Fang Huang; Yang Yu-Wei Lin; Wei-Yang Chang; Wen-Lang Fan; Chin-Yi Yang; Ji-Chen Ho; Ya-Ching Chang; Chun-Wei Lu; Wen-Hung Chung
Journal:  J Clin Invest       Date:  2018-02-05       Impact factor: 14.808

2.  RIPping the Skin Apart: Necroptosis Signaling in Toxic Epidermal Necrolysis.

Authors:  Diana Panayotova-Dimitrova; Maria Feoktistova; Martin Leverkus
Journal:  J Invest Dermatol       Date:  2015-08       Impact factor: 8.551

3.  IL-12p40 impairs mesenchymal stem cell-mediated bone regeneration via CD4+ T cells.

Authors:  Jiajia Xu; Yiyun Wang; Jing Li; Xudong Zhang; Yiyun Geng; Yan Huang; Kerong Dai; Xiaoling Zhang
Journal:  Cell Death Differ       Date:  2016-07-29       Impact factor: 15.828

4.  Upregulated RIP3 Expression Potentiates MLKL Phosphorylation-Mediated Programmed Necrosis in Toxic Epidermal Necrolysis.

Authors:  Sue Kyung Kim; Woo-Jung Kim; Jung-Ho Yoon; Jae-Hoon Ji; Michael J Morgan; Hyeseong Cho; You Chan Kim; You-Sun Kim
Journal:  J Invest Dermatol       Date:  2015-03-06       Impact factor: 8.551

5.  Fas/Fas ligand mediates keratinocyte death in sunitinib-induced hand-foot skin reaction.

Authors:  Chun-Nan Yeh; Wen-Hung Chung; Shih-Chi Su; Yen-Yang Chen; Chi-Tung Cheng; Yen-Ling Lin; Wan-Chun Chang; Rosaline Chung-Yee Hui; Kun-Chun Chiang; Tsung-Wen Chen; Yi-Yin Jan; Chien-Wei Chen; Ting-Jui Chen; Chih-Hsun Yang; Shuen-Iu Hung
Journal:  J Invest Dermatol       Date:  2014-05-06       Impact factor: 8.551

6.  Nanoparticle delivery of CDDO-Me remodels the tumor microenvironment and enhances vaccine therapy for melanoma.

Authors:  Yan Zhao; Meirong Huo; Zhenghong Xu; Yuhua Wang; Leaf Huang
Journal:  Biomaterials       Date:  2015-08-01       Impact factor: 12.479

Review 7.  Mechanisms of Severe Cutaneous Adverse Reactions: Recent Advances.

Authors:  Teresa Bellón
Journal:  Drug Saf       Date:  2019-08       Impact factor: 5.228

Review 8.  Current Perspectives on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.

Authors:  Marianne Lerch; Carlo Mainetti; Benedetta Terziroli Beretta-Piccoli; Thomas Harr
Journal:  Clin Rev Allergy Immunol       Date:  2018-02       Impact factor: 10.817

9.  Association of interleukin-6 and tumor necrosis factor-α with mortality in hospitalized patients with cancer.

Authors:  Joseph R Stoll; Toral S Vaidya; Shoko Mori; Stephen W Dusza; Mario E Lacouture; Alina Markova
Journal:  J Am Acad Dermatol       Date:  2020-03-12       Impact factor: 11.527

Review 10.  Lamotrigine and Stevens-Johnson Syndrome Prevention.

Authors:  Amber N Edinoff; Long H Nguyen; Mary Jo Fitz-Gerald; Erin Crane; Kyle Lewis; Samantha St Pierre; Alan D Kaye; Adam M Kaye; Jessica S Kaye; Rachel J Kaye; Sonja A Gennuso; Giustino Varrassi; Omar Viswanath; Ivan Urits
Journal:  Psychopharmacol Bull       Date:  2021-03-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.